LeMaitre Vascular (LMAT) Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, community ranking, analyst recommendations, risk and earnings.

Do institutionals and insiders hold more shares of STVN or LMAT?

84.6% of LeMaitre Vascular shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 10.8% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is STVN or LMAT a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 1.0%. Stevanato Group pays out 12.5% of its earnings in the form of a dividend. LeMaitre Vascular pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has raised its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Does the media favor STVN or LMAT?

In the previous week, Stevanato Group had 2 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Stevanato Group and 6 mentions for LeMaitre Vascular. Stevanato Group's average media sentiment score of 1.00 beat LeMaitre Vascular's score of 0.82 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable valuation and earnings, STVN or LMAT?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. Stevanato Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.10B	5.45	$157.62M	$0.48	41.42
LeMaitre Vascular	$219.86M	8.40	$30.10M	$1.94	42.22

Do analysts rate STVN or LMAT?

LeMaitre Vascular has a consensus price target of $95.25, suggesting a potential upside of 16.29%. Given LeMaitre Vascular's higher possible upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.67

Is STVN or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
LeMaitre Vascular	19.40%	13.15%	11.47%

Which has more risk and volatility, STVN or LMAT?

Stevanato Group has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

Does the MarketBeat Community favor STVN or LMAT?

LeMaitre Vascular received 485 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%

Summary

LeMaitre Vascular beats Stevanato Group on 15 of the 22 factors compared between the two stocks.